Python Metabolism Study Reveals Potential New Weight-Loss Molecule

Research published on March 19 in Nature Metabolism has identified a molecule in python blood that suppresses appetite in mice, potentially leading to new weight-loss therapies. Scientists from Stanford University and the University of Colorado Boulder studied Burmese pythons and ball pythons, which can fast for extended periods after large meals. They discovered that para-tyramine-O-sulfate (pTOS), a metabolite that increases dramatically after feeding, reduces food intake in obese mice without causing gastrointestinal side effects associated with current GLP-1 drugs like Ozempic and Wegovy. The molecule targets the hypothalamus region of the brain rather than the stomach, differing from existing treatments. While more research is needed, this discovery follows a pattern of nature-inspired medical advances, as GLP-1 drugs were originally derived from Gila monster venom. The study involved analyzing blood samples from fasting and fed pythons, identifying 208 metabolites that changed significantly after meals.